These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 17980002

  • 1. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML, Ulied A, Casanueva FF, Pico A, Lucas T, Torres E, Sanmartí A.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [Abstract] [Full Text] [Related]

  • 2. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 Jun; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 3. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
    Thissen JP, Ketelslegers JM, Maiter D.
    Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
    [Abstract] [Full Text] [Related]

  • 4. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
    Fukuda I, Hizuka N, Ishikawa Y, Itoh E, Yasumoto K, Murakami Y, Sata A, Tsukada J, Kurimoto M, Okubo Y, Takano K.
    Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
    [Abstract] [Full Text] [Related]

  • 5. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
    Massart C, Poirier JY.
    Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
    [Abstract] [Full Text] [Related]

  • 6. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay.
    Kratzsch J, Blum WF, Schenker E, Keller E, Jahreis G, Haustein B, Ventz M, Rotzsch W.
    Exp Clin Endocrinol; 1993 Nov; 101(3):144-9. PubMed ID: 8223982
    [Abstract] [Full Text] [Related]

  • 7. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B, Smethurst LE, Mukherjee A, Jostel A, Shalet SM, Murray RD.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 9. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A, Terzolo M, Bondanelli M, Galderisi M, Vitale G, Reimondo G, Ambrosio MR, Pivonello R, Lombardi G, Angeli A, degli Uberti EC.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F.
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [Abstract] [Full Text] [Related]

  • 11. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O, Góth M, Szabolcs I, Kovács L, Kovács Z, Szilágyi G.
    Orv Hetil; 1993 Oct 17; 134(42):2301-3. PubMed ID: 8233444
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population.
    Granada ML, Murillo J, Lucas A, Salinas I, Llopis MA, Castells I, Foz M, Sanmartí A.
    Eur J Endocrinol; 2000 Mar 17; 142(3):243-53. PubMed ID: 10700718
    [Abstract] [Full Text] [Related]

  • 13. The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.
    Varewijck AJ, Lamberts SW, van der Lely AJ, Neggers SJ, Hofland LJ, Janssen JA.
    J Clin Endocrinol Metab; 2015 Jan 17; 100(1):309-16. PubMed ID: 25337924
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone deficiency (GHD) in adult thalassaemic patients.
    Scacchi M, Danesi L, Cattaneo A, Valassi E, Pecori Giraldi F, Argento C, D'Angelo E, Mirra N, Carnelli V, Zanaboni L, Cappellini MD, Cavagnini F.
    Clin Endocrinol (Oxf); 2007 Nov 17; 67(5):790-5. PubMed ID: 17608814
    [Abstract] [Full Text] [Related]

  • 15. Normal reference range of serum insulin-like growth factor (IGF)-I in healthy Thai adults.
    Plengpanich W, Mangkala J, Buranasukajorn P, Boonruang K, Sunthornyothin S, Suwanwalaikorn S, Khovidhunkit W, Sridama V, Snabboon T.
    J Med Assoc Thai; 2008 Nov 17; 91(11):1681-4. PubMed ID: 19127789
    [Abstract] [Full Text] [Related]

  • 16. Acromegaly and serum insulin-like growth factor I.
    Thorner MO.
    Horm Res; 2004 Nov 17; 62 Suppl 1():34-6. PubMed ID: 15761230
    [Abstract] [Full Text] [Related]

  • 17. Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD.
    Lissett CA, Jönsson P, Monson JP, Shalet SM, KIMS International Board.
    Clin Endocrinol (Oxf); 2003 Dec 17; 59(6):773-8. PubMed ID: 14974921
    [Abstract] [Full Text] [Related]

  • 18. Establishment of reference values for endocrine tests--part V: acromegaly.
    Endert E, van Rooden M, Fliers E, Prummel MF, Wiersinga WM.
    Neth J Med; 2006 Dec 17; 64(7):230-5. PubMed ID: 16929084
    [Abstract] [Full Text] [Related]

  • 19. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register.
    Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM, Grussendorf M, Reincke M, Participants of the German Acromegaly Register.
    Clin Endocrinol (Oxf); 2009 Sep 17; 71(3):400-5. PubMed ID: 19226273
    [Abstract] [Full Text] [Related]

  • 20. Use of the oral glucose tolerance test to define remission in acromegaly.
    Vierhapper H, Heinze G, Gessl A, Exner M, Bieglmayr C.
    Metabolism; 2003 Feb 17; 52(2):181-5. PubMed ID: 12601629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.